The shareholders of Ruetschi Group, a Swiss based MedTech company engaged in the development and production of high-tech implants and instruments for the medical industry, have sold their shares to Klingel Medical Metal Group, a
Credit Suisse, MoneyPark and PriceHubble enter into a strategic partnership that will combine digital banking and financing from Credit Suisse, real-estate and mortgage services by MoneyPark and big data and analytics from PriceHubble. By joining
The shareholders of video intelligence, a Swiss-based contextual video technology platform for digital and Connected TV media owners, have entered into a share purchase agreement regarding the sale of video intelligence to Outbrain, a recommendation
TVS Motor company, a global automotive manufacturer company, acquires a majority stake in the Swiss company the GO corporation and its e-bike brand EGO Movement, through its Singapore subsidiary TVS Motor (Singapore). This partnership is
The Netrics Group, a portfolio company of Waterland Private Equity, takes over BlueStone Consulting Group, a provider of cloud platforms in the Infrastructure as a Service (IaaS) and Modern Workplace sector. Bär &
Niederer Kraft Frey acted as lead counsel to CGS Management, owner of Kalt Maschinenbau, on the add-on acquisition of staedler automation. Kalt Maschinenbau, international specialist in cheese, dairy and process technology, and staedler automation, a
iRobot, a developer for consumer robots, has acquired privately-held Aeris Cleantec, a fast-growing provider of premium air purifiers headquartered in Cham, Zug Switzerland. The acquisition supports iRobot’s vision of building the world’s most
Falcon Private, a Swiss private banking boutique based in Zürich, Switzerland, has sold all its shares in Falcon Private Wealth Limited, Dubai, to ONE swiss bank. This agreement comes shortly after
The Court of Arbitration for Sport (CAS) has dismissed the appeal of the German National Anti Doping Agency (NADA) against the first instance award of the German Sports Arbitration Court of the German Institution of
Relief Therapeutics, a biopharmaceutical company, has launched a Level 1 American Depositary Receipt (“ADR”) program in the United States. From 18 November 2021, ADRs can be traded over-the-counter. Relief’s ADR program complements the existing main listing of
